The Inflection Point for Pharma Quality For decades, quality functions in pharmaceutical organizations have been viewed through a narrow lens—cost centers focused on compliance, deviation management, and regulatory readiness. While this approach ensured patient safety and regulatory adherence, it limited the true strategic potential of Quality. Today, leading pharmaceutical MNCs are at a critical inflection …
Continue reading “Operational Excellence in Quality: Moving Beyond Cost to Value Creation”